A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

NCT06092762 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso